North America Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others), End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country
- THE3207047
- 189 Pages
- April 2019
- Diagnostic and Biotech
The growth of the genomics market is primarily attributed to the growth in investments & funds for genomics and declining cost of sequencing procedures. However, t high cost of equipment used in genomics and limitations in genomics are likely to pose a negative impact on the market growth. On the other hand, scopes for the consumer genomics is likely to have a positive impact on the growth of the North America genomics market in the coming years.
The cost of genome sequencing has been dropping radically, nearly a million-fold in the past six-seven years. In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took more than a decade for the completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. The decline in the cost can be checked by the cost to sequence a genome diverging drastically around 2008, falling from approximately US$ 10 million to nearly US$ 1,000 at the present date.
The rapid reduction in costs have now helped in clinical research, but even greater speed and a lowered price point will likely be enticing to health startups for the help of consumers. The first sequencing of the whole human genome in 2003 cost approximately US$ 2.7 Bn, but DNA sequencing company, Illumina has launched the latest and advanced machine for the whole genome sequencing and it costs for less than US$ 100. The price for genome sequencing has been in continuous free fall since the establishment. In 2006, Illumina’s first machine which was used for the sequencing of a human genome for US$ 300,000, and in 2014 the company revealed the cost of the same sequencing for that has been reduced to US$ 1,000. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.
Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing.
In 2017, the sequencing segment held a largest market share of 38.1% of the genomics market, by technology. This segment is also expected to dominate the market in 2025 owing to higher acceptance of the sequencing procedures for the genomics. Furthermore, the microarray segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.
North America genomics market, based on product & service was segmented into instrument/systems, consumables and services. In 2017, the consumables segment held a largest market share of 46.5% of the genomics market. The segment is anticipated to grow at a CAGR of 10.9% during the forecast period. Moreover, the services segment is expected to grow at the fastest rate at 11.8% during the coming years.
By application, the diagnostics segment is anticipated to grow at a CAGR of 11.6% during the forecast period. The diagnostics helps benefit the human to avoid the inheritance of the diseases in their children and diagnostics provides clarity for more concise treatment. Moreover, the segment held the largest market share of 32.2% for the application segment in the genomics market and is likely to dominate the market in coming forecast period.
In 2017, the research centers segment held a largest market share of 42.3% of the genomics market, by end user. This segment is also expected to dominate the market in 2025. However, the hospitals & clinics segment is anticipated to witness the fastest growth rate of 11.5% during the forecast period, 2017 to 2025. This higher growth rate of the segment owing to the providing the references for further researches are likely to propel the growth of the research centers segment in the coming future.
Some of the major primary and secondary sources for genomics included in the report are, Association for Responsible Research and Innovation in Genomics (ARRIGE), Biotechnology Industry Research Assistance Council (BIRAC), Defense Advanced Research Projects Agency (DARPA), Department of Biotechnology (DBT), Food and Drug Administration (FDA) and among others.
PART 1. INTRODUCTION
1.1 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
PART 2. NORTH AMERICA GENOMICS MARKET - KEY TAKEAWAYS
PART 3. NORTH AMERICA GENOMICS MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 North America Genomics Market - By Technology
3.2.2 North America Genomics Market - By Product & Services
3.2.3 North America Genomics Market - By Application
3.2.4 North America Genomics Market - By End User
3.2.5 North America Genomics Market - By Country
3.3 PEST ANALYSIS
PART 4. NORTH AMERICA GENOMICS MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Growth in Investments & Funds for Genomics
4.1.2 Declining Cost of Sequencing Procedures
4.2 KEY MARKET RESTRAINTS
4.2.1 High Cost of Equipment Used in Genomics
4.2.2 Limitations in Genomics
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Scopes for the Consumer Genomics
4.4 FUTURE TRENDS
4.4.1 Technologies of Genomics
4.5 IMPACT ANALYSIS
PART 5. GENOMICS MARKET - NORTH AMERICA ANALYSIS
5.1 NORTH AMERICA GENOMICS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING/ MARKET SHARE
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 Illumina, Inc.
5.4 EXPERT OPINIONS
PART 6. NORTH AMERICA GENOMICS MARKET ANALYSIS - BY TECHNOLOGY
6.1 OVERVIEW
6.2 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%)
6.3 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
6.4 SEQUENCING MARKET
6.4.1 Overview
6.4.2 North America Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 MICROARRAY MARKET
6.5.1 Overview
6.5.2 North America Microarray Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 POLYMERASE CHAIN REACTION (PCR) MARKET
6.6.1 Overview
6.6.2 North America Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET
6.7.1 Overview
6.7.2 North America Nucleic Acid Extraction and Purification Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 OTHERS MARKET
6.8.1 Overview
6.8.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. NORTH AMERICA GENOMICS MARKET ANALYSIS - BY PRODUCT & SERVICE
7.1 OVERVIEW
7.2 NORTH AMERICA GENOMICS MARKET, BY PRODUCT & SERVICE, 2017 & 2025 (%)
7.3 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
7.4 INSTRUMENTS/SYSTEMS MARKET
7.4.1 Overview
7.4.2 North America Instruments/Systems Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CONSUMABLES MARKET
7.5.1 Overview
7.5.2 North America Consumables Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 SERVICES MARKET
7.6.1 Overview
7.6.2 North America Services Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. NORTH AMERICA GENOMICS MARKET ANALYSIS - BY APPLICATION
8.1 OVERVIEW
8.2 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, 2017 & 2025 (%)
8.3 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
8.4 DIAGNOSTICS MARKET
8.4.1 Overview
8.4.2 North America Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 DRUG DISCOVERY & DEVELOPMENT MARKET
8.5.1 Overview
8.5.2 North America Drug Discovery & Development Market Revenue and Forecasts to 2025 (US$ Mn)
8.6 PRECISION/PERSONALIZED MEDICINE MARKET
8.6.1 Overview
8.6.2 North America Precision/Personalized Medicine Market Revenue and Forecasts to 2025 (US$ Mn)
8.7 AGRICULTURE & ANIMAL RESEARCH MARKET
8.7.1 Overview
8.7.2 North America Agriculture & Animal Research Market Revenue and Forecasts to 2025 (US$ Mn)
8.8 OTHERS MARKET
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. NORTH AMERICA GENOMICS MARKET ANALYSIS - BY END USER
9.1 OVERVIEW
9.2 NORTH AMERICA GENOMICS MARKET, BY END USER, 2017 & 2025 (%)
9.3 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
9.4 RESEARCH CENTERS MARKET
9.4.1 Overview
9.4.2 North America Research Centers Market Revenue and Forecasts to 2025 (US$ Mn)
9.5 HOSPITALS & CLINICS MARKET
9.5.1 Overview
9.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2025 (US$ Mn)
9.6 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
9.6.1 Overview
9.6.2 North America Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)
9.7 OTHERS MARKET
9.7.1 Overview
9.7.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 10. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025
10.1 OVERVIEW
10.2 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.3 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
10.4 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
10.5 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
10.6 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
10.7 NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
10.8 US GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.8.1 US Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
10.8.2 US Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.8.3 US Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.8.4 US Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.8.5 US Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
10.9 CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.9.1 Canada Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
10.9.2 Canada Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.9.3 Canada Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.9.4 Canada Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.9.5 Canada Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
10.10 MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.10.1 Mexico Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
10.10.2 Mexico Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.10.3 Mexico Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.10.4 Mexico Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.10.5 Mexico Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
PART 11. GENOMICS MARKET -INDUSTRY LANDSCAPE
11.1 OVERVIEW
11.2 GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018
11.3 ORGANIC GROWTH STRATEGIES
11.3.1 Overview
11.3.2 Product Launch
11.3.3 Approvals
11.3.4 Expansion
11.3.5 Product Expansion
11.3.6 Others
11.4 INORGANIC GROWTH STRATEGIES
11.4.1 Overview
11.4.2 Partnership
11.4.3 Acquisition
11.4.4 Collaboration
11.4.5 Agreement
PART 12. GENOMICS MARKET -KEY COMPANY PROFILES
12.1 BEIJING GENOMICS INSTITUTE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product & Services Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DANAHER
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BIO-RAD LABORATORIES, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GENERAL ELECTRIC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 THERMOFISHER SCIENTIFIC INC.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AGILENT TECHNOLOGIES
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ILLUMINA, INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 EUROFINS SCIENTIFIC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product/ Services Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 QIAGEN
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 Swot Analysis
12.10.6 Key Developments
PART 13. APPENDIX
13.1 ABOUT THE INSIGHT PARTNERS
13.2 GLOSSARY OF TERMS
13.3 METHODOLOGY
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
TABLE 1. PRICE OF VARIOUS NGS MACHINES OF SOME MAJOR PLAYERS
TABLE 2. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 3. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
TABLE 4. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 5. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 6. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 7. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
TABLE 8. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 9. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 10. US GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 11. US GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
TABLE 12. US GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. US GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 14. CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 15. CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)
TABLE 16. CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 17. CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 18. MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)
TABLE 19. MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN)
TABLE 20. MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 21. MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)
TABLE 22. RECENT PRODUCT LAUNCH IN THE GENOMICS MARKET
TABLE 23. PRODUCT ENHANCEMENT & SOFTWARE UPGRADATION IN THE GENOMICS MARKET
TABLE 24. EXPANSION ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET
TABLE 25. PRODUCT EXPANSION ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET
TABLE 26. OTHERS ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET
TABLE 27. RECENT PARTNERSHIP IN THE GENOMICS MARKET
TABLE 28. RECENT ACQUISITION IN THE GENOMICS MARKET
TABLE 29. RECENT COLLABORATION IN THE GENOMICS MARKET
TABLE 30. RECENT AGREEMENT IN THE GENOMICS MARKET
TABLE 31. GLOSSARY OF TERMS, GENOMICS MARKET
LIST OF FIGURES
FIGURE 1. US GENOMICS MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025
FIGURE 2. NORTH AMERICA GENOMICS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017
FIGURE 3. NORTH AMERICA GENOMICS MARKET BY PRODUCT & SERVICE, MARKET SHARE (%), 2017
FIGURE 4. NORTH AMERICA GENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2017
FIGURE 5. NORTH AMERICA GENOMICS MARKET BY END USER, MARKET SHARE (%), 2017
FIGURE 6. GENOMICS MARKET SEGMENTATION
FIGURE 7. NORTH AMERICA PEST ANALYSIS
FIGURE 8. GENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 9. NORTH AMERICA GENOMICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
FIGURE 10. NORTH AMERICA GENOMICS MARKET - KEY MARKET PLAYERS
FIGURE 11. NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%)
FIGURE 12. NORTH AMERICA SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 13. NORTH AMERICA MICROARRAY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 14. NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 15. NORTH AMERICA NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 16. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. NORTH AMERICA GENOMICS MARKET BY PRODUCT & SERVICE, 2017 & 2025 (%)
FIGURE 18. NORTH AMERICA INSTRUMENTS/SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. NORTH AMERICA CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) ERROR! BOOKMARK NOT DEFINED.
FIGURE 20. NORTH AMERICA SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. NORTH AMERICA GENOMICS MARKET BY APPLICATION, 2017 & 2025 (%)
FIGURE 22. NORTH AMERICA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) ERROR! BOOKMARK NOT DEFINED.
FIGURE 23. NORTH AMERICA DRUG DISCOVERY & DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 24. NORTH AMERICA PRECISION/PERSONALIZED MEDICINE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. NORTH AMERICA AGRICULTURE & ANIMAL RESEARCH MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 26. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. NORTH AMERICA GENOMICS MARKET BY END USER, 2017 & 2025 (%)
FIGURE 28. NORTH AMERICA RESEARCH CENTERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 29. NORTH AMERICA HOSPITALS & CLINICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 30. NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 31. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 32. NORTH AMERICA GENOMICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 33. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 34. NORTH AMERICA GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 35. US GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 36. CANADA GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 37. MEXICO GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 38. GROWTH STRATEGIES IN THE GENOMICS DEVICES MARKET, 2015-2018
FIGURE 39. ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018
FIGURE 40. INORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
